Trial intelligence / Profile preview

Effect of anastrozole on arthralgia and glucosamine sulphate supplementation in IBIS-II prevention

2009-015378-36Phase 3Terminated

Sponsor
Queen Mary University of London
Start
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of glucosamine sulphate in arthralgia, sponsored by Queen Mary University of London. Primary endpoint: Presence or absence of arthralgia at 6 months. Started Nov 2010; status: terminated.

02

Drugs

glucosamine sulphate
03

Conditions

arthralgia

Beyond the preview

Go deeper on 2009-015378-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015378-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call